KRAS G12C inhibitor 49
KRAS G12C inhibitor 49 is an orally bioavailable small molecule that selectively targets the KRAS G12C mutant protein. It demonstrates potent anti-tumor activity in both cellular assays and in vivo animal models, making it a valuable tool for oncology research targeting RAS-driven cancers.
Product Specifications
CAS Number
2761380-32-7
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
O=C1N (C=2C (C (=N1) N3C (C) CN (C (C=C) =O) CC3) =CC (Cl) =C (N2) C4=C (C=O) C=CC=C4) C5=C (C (C) C) N=CC=C5C
Molecular Formula
C31H31ClN6O3
Molecular Weight
571.07
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040806-100 1x 100 µL
TYRP1 (Tyrosinase Related Protein 1) (TA99), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472176-100 1x 100 µL
MMP9 (rMMP9/1769), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742343-100 1x 100 µL
CD9 (TSPAN29) (Motility-Related Protein-1) (CD9/2343), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040499-500 1x 500 µL
Cytokeratin 14 (LL002), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740639-500 1x 500 µL
CD31 / PECAM-1 (JC/70A), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 